Clinical Trial

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A Prospective, Multicenter, Non-Interventional Study of Primary Data Collection, Designed to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcomes in Patients with Breast Cancer in Latin America.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-30 -> 2026-07-31 2026-07-16
minor Completion pushed: 2026-06-30 -> 2026-07-31 2026-07-16
Trial Details
NCT Number NCT04158258
Lead Sponsor Hoffmann-La Roche
Collaborators: Latin American Cooperative Oncology Group
Conditions Breast Cancer
Enrollment 2,907 participants
Start Date 2020-02-21
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-15